Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane is a fundamental phospholipid bilayer that serves as a selective barrier and a scaffold for essential biological processes, including ATP synthesis and nutrient transport (Alberts et al., "Molecular Biology of the Cell"). It is intrinsically linked to associated surface proteins such as penicillin-binding proteins (PBPs), which are crucial for peptidoglycan synthesis and maintaining cell shape (Sauvage et al., 2008, "The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis"). In clinical medicine, this structure is a vital therapeutic target for treating various bacterial infections, ranging from skin infections to life-threatening sepsis (StatPearls, "Antibiotics"). Antibiotics like daptomycin target the membrane by inserting into the bilayer in a calcium-dependent manner, causing rapid depolarization and cell death (PubChem, "Daptomycin"). Polymyxins, such as Colistin, interact with the lipopolysaccharides of Gram-negative bacteria to disrupt membrane integrity (StatPearls, "Polymyxin B"). While highly effective, targeting the bacterial membrane can present safety challenges, including nephrotoxicity and neurotoxicity, due to potential off-target effects or high dosage requirements (PubMed, "Toxicity of Polymyxins").
Drugs targeting this complex typically act by inducing membrane depolarization, forming transmembrane pores, or inhibiting the activity of surface-associated enzymes like penicillin-binding proteins (PBPs). These actions lead to the leakage of essential intracellular ions, loss of membrane potential, or the cessation of cell wall synthesis, ultimately resulting in rapid bacterial cell death (StatPearls, "Antibiotics"; PubChem, "Daptomycin").
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and associated surface proteins.